Fundamental Analysis of TFF PHARMACEUTICALS INC(NASDAQ:TFFP) stock

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to TFFP. TFFP was compared to 193 industry peers in the Pharmaceuticals industry. While TFFP seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, TFFP is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year TFFP has reported negative net income.

In the past year TFFP has reported a negative cash flow from operations.

TFFP had negative earnings in each of the past 5 years.

In the past 5 years TFFP always reported negative operating cash flow.

1.2 Ratios

TFFP has a worse Return On Assets (-261.68%) than 92.67% of its industry peers.

TFFP has a Return On Equity of -590.38%. This is amonst the worse of the industry: TFFP underperforms 81.68% of its industry peers.

		Industry Rank	Sector Rank
ROA	-261.68%
ROE	-590.38%
ROIC	N/A

ROA(3y)-128.2%

ROA(5y)-111.66%

ROE(3y)-147.01%

ROE(5y)-124.69%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TFFP so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TFFP does not have a ROIC to compare to the WACC, probably because it is not profitable.

TFFP has less shares outstanding than it did 1 year ago.

TFFP has less shares outstanding than it did 5 years ago.

TFFP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

TFFP has an Altman-Z score of -34.71. This is a bad value and indicates that TFFP is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -34.71, TFFP is doing worse than 91.62% of the companies in the same industry.

There is no outstanding debt for TFFP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-34.71

ROIC/WACCN/A

WACC9.43%

2.3 Liquidity

TFFP has a Current Ratio of 0.89. This is a bad value and indicates that TFFP is not financially healthy enough and could expect problems in meeting its short term obligations.

TFFP has a Current ratio of 0.89. This is amonst the worse of the industry: TFFP underperforms 89.53% of its industry peers.

TFFP has a Quick Ratio of 0.89. This is a bad value and indicates that TFFP is not financially healthy enough and could expect problems in meeting its short term obligations.

TFFP has a worse Quick ratio (0.89) than 83.25% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.89
Quick Ratio	0.89

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.46% over the past year.

The Revenue has grown by 25.57% in the past year. This is a very strong growth!

EPS 1Y (TTM)50.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%64%

Revenue 1Y (TTM)25.57%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-17.71%

3.2 Future

Based on estimates for the next years, TFFP will show a very strong growth in Earnings Per Share. The EPS will grow by 21.17% on average per year.

The Revenue is expected to grow by 153.49% on average over the next years. This is a very strong growth

EPS Next Y65.1%

EPS Next 2Y30.1%

EPS Next 3Y21.17%

EPS Next 5YN/A

Revenue Next Year60.13%

Revenue Next 2Y5.41%

Revenue Next 3Y153.49%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TFFP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year TFFP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

TFFP's earnings are expected to grow with 21.17% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y30.1%

EPS Next 3Y21.17%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TFFP does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TFF PHARMACEUTICALS INC

NASDAQ:TFFP (12/12/2024, 8:00:00 PM)

After market: 0.135 +0.07 (+107.69%)

0.065

-0.1 (-60.05%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap288.60K

Analysts

Price Target

Short Float %

Short Ratio

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-261.68%
ROE	-590.38%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.16

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.89
Quick Ratio	0.89
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)50.46%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y65.1%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)25.57%

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

TFF PHARMACEUTICALS INC (TFFP)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens